MRD / Regn No. : SG004598 Date : 20/06/2026
Patient Name : Suman Das Age & Gender : 40 Yrs. / Male
Contact No. : 7003399815 UHID :
Ht / Wt / BMI : 181 / 104 / 31.75 BP S / BP D : 132 / 85
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (20/Jun/2026) | MASLD (20/Jun/2026) | DYSLIPIDEMIA (20/Jun/2026) | OBESITY (20/Jun/2026) |
Salient Investigations : TGL TRIGLYCERIDE: 198 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.2 % | LDL LOW DENSITY LIPOPROTEIN: 131 mg/dL | ALT ALANINE AMINOTRANSFERASE: 356 IU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC 		SC ONCE A WEEK AFTER BREAKFAST
 4 WEEKS
2 ANTIHYPERGLYCEMIC SEMAGLUTIDE 5.0 MG
OZEMPIC 0.5 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 20/Aug/2026
Tests Suggested For Next Visit : FPG,PPG,LDL-C,FIBROSCAN (CAP & LSM)
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: